Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction.
about
Primary medication non-adherence: analysis of 195,930 electronic prescriptionsThe impracticality of biomedical rejuvenation therapies: translational and pharmacological barriersPotential savings of harmonising hospital and community formularies for chronic disease medications initiated in hospitalHealth system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic reviewProlonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populationsMaintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2).The Use of Text Messaging to Improve the Hospital-to-Community Transition in Acute Coronary Syndrome Patients (Txt2Prevent): Intervention Development and Pilot Randomized Controlled Trial ProtocolLow literacy is associated with uncontrolled blood pressure in primary care patients with hypertension and heart disease.Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study.Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data.Measuring data reliability for preventive services in electronic medical recordsSouthern Saskatchewan Ticagrelor Registry experience.The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial.Effectiveness of treat-to-target strategy for LDL-cholesterol control in type 2 diabetes: post-hoc analysis of data from the MIND.IT study.Improving medication adherence in hypercholesterolemia: challenges and solutions.Primary medication non-adherence after discharge from a general internal medicine service.Blood pressure trajectories and associations with treatment intensification, medication adherence, and outcomes among newly diagnosed coronary artery disease patients.The changing epidemiology of myocardial infarction in Olmsted County, Minnesota, 1995-2012.Delay in filling first clopidogrel prescription after coronary stenting is associated with an increased risk of death and myocardial infarctionEvidence of poor adherence to secondary prevention after acute coronary syndromes: possible remedies through the application of new technologiesRacial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.National Background is Associated with Disparities in Initiation and Persistence to Statin Treatment in Subjects with Diabetes in Denmark.Prevalent but moderate variation across small geographic regions in patient nonadherence to evidence-based preventive therapies in older adults after acute myocardial infarctionImplementation of electronic medical records: effect on the provision of preventive services in a pay-for-performance environment.The burden of non-adherence to cardiovascular medications among the aging population in Australia: a meta-analysis.Participation Rates, Process Monitoring, and Quality Improvement Among Cardiac Rehabilitation Programs in the United States: A NATIONAL SURVEYClopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stentHow patient cost-sharing trends affect adherence and outcomes: a literature review.Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATApplication of a framework for determining number of drugs.Implementing shared decision making in federally qualified health centers, a quasi-experimental design study: the Office-Guidelines Applied to Practice (Office-GAP) program.Exploring Transitional Care: Evidence-Based Strategies for Improving Provider Communication and Reducing ReadmissionsUse of medicines recommended for secondary prevention of acute coronary syndrome.Persistence of evidence-based medication use after discharge from academic versus nonacademic hospitals among patients with non-ST-segment elevation myocardial infarctionRefractory primary medication nonadherence: Prevalence and predictors after pharmacist counseling at hospital discharge.Medication Nonadherence Before Hospitalization for Acute Cardiac EventsComparative cost-effectiveness of interventions to improve medication adherence after myocardial infarctionEffect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults.Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates.
P2860
Q24619145-95AB2A5B-3C9E-4C27-8E03-627D0365BFC4Q28392956-28CE293F-A54B-42C5-8C25-508C933656BCQ28480623-C75EC6CB-18AE-4C5B-B269-CDB042325BDCQ28554270-43DD68B3-B50B-4F97-B1CF-242F46DE0230Q28600880-F83D7BF7-9BDF-48D7-AD6B-AD4ADCFA2EC6Q30736002-FCDE713B-4884-468A-9B78-97D817BA37DBQ33770697-064974B0-E26F-447A-A5AC-76C0D833C3E7Q33915728-1AE34BFE-4302-4307-AEE9-1B498C832E5AQ34084953-F4910E1D-7672-4998-ABE8-C657CC240B71Q34220461-A055A5A0-3410-4629-988A-B99F2BFADD4FQ34268123-E325AC98-340F-4ED4-A061-673884CE2861Q34387201-528FE996-6B19-4CF5-820F-4C7B5EA2ACF5Q34408135-284C3803-5CEE-4D8A-84C6-F894D4E5B2DCQ34475329-EAA1557F-99D9-4C3A-AA72-42224A045D8DQ34482456-FEFC5DD6-D13F-4024-9A9B-B6E9627F26E1Q34712375-B5380EF6-C3EC-46E9-BA4D-3E65A662254DQ34753242-B808BEF0-829D-47BC-80BB-19FAEB270CAFQ35014123-CFEAD7A5-1DF1-4DB0-B66E-16356E7905B1Q35021774-CAA57610-4339-49EB-B653-38584D96A759Q35086213-C269DFA7-7C75-4CBC-969A-BDB028DC6560Q35153905-A9A33583-1ED2-4392-A1EB-2679315FB1DCQ35155256-EB7925F8-B4B4-4DA7-8642-B3C3DF31BB54Q35178428-9584130E-E069-470F-9483-88992E61752EQ35330530-1281AE0B-4ED8-4DC8-89CF-B694C2C59DE8Q35573404-70CE07D6-10D3-4AB7-BFF8-4198A36F4758Q35665914-6185DF09-F028-4B9F-B905-9AC21214490BQ35680854-F6CC20AB-B525-43B8-AF19-CEE570FCD5A9Q35752951-3EB28130-C5CB-41A5-91A7-3F1A3993AC53Q35755660-B9BDFD57-A4DC-4373-9FAF-15C37F6F899DQ35883262-27C50C63-6340-481F-945F-EB7915B2CF6DQ36017719-FC4099FB-8AF2-4225-9E1D-7A4242C2FA3FQ36092878-D88B29E8-9984-4392-B6ED-04E71BCC3C5AQ36164731-7445A80F-385F-40B7-981D-F409F4CA2CCBQ36395016-16A6281F-A7FA-4798-874B-A1E734228735Q36404529-F37A14B5-EED5-4D5C-81B1-2E4792D6B796Q36436867-02FAB95A-E664-4C2D-8E69-9C4630FDF27FQ36443765-B3579ECD-B471-4286-A5EC-EAD6630675C1Q36469832-7572C333-E02B-45A1-9F71-62DA90D84AEEQ36521022-6FFC8CDF-9DC5-4720-B77B-D96D033AF466Q36661519-83F5F429-5185-4DAD-8746-3D4E8E5F0B80
P2860
Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Prevalence, predictors, and ou ...... r acute myocardial infarction.
@en
Prevalence, predictors, and ou ...... r acute myocardial infarction.
@nl
type
label
Prevalence, predictors, and ou ...... r acute myocardial infarction.
@en
Prevalence, predictors, and ou ...... r acute myocardial infarction.
@nl
prefLabel
Prevalence, predictors, and ou ...... r acute myocardial infarction.
@en
Prevalence, predictors, and ou ...... r acute myocardial infarction.
@nl
P1433
P1476
Prevalence, predictors, and ou ...... r acute myocardial infarction.
@en
P2093
Cynthia A Jackevicius
P304
P356
10.1161/CIRCULATIONAHA.107.706820
P407
P50
P577
2008-02-01T00:00:00Z